Respimat

Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Its developer, Boehringer Ingelheim, is currently^[when?] conducting approved in the U.S. with a variety of their products, such as tiotropium and ipratropium/salbutamol. According to the manufacturer, the reusability of the inhaler reduces its carbon footprint by 71%.^[1]

References

^ "First reusable, propellant-free inhaler launched to cut plastic waste". Pharmaceutical Journal. 17 September 2019. Retrieved 19 November 2019.

Sources

Home — Respimat International

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] "First reusable, propellant-free inhaler launched to cut plastic waste". Pharmaceutical Journal. 17 September 2019. Retrieved 19 November 2019.

[1]